| __timestamp | Taro Pharmaceutical Industries Ltd. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55430000 | 18516000 |
| Thursday, January 1, 2015 | 65510000 | 34140000 |
| Friday, January 1, 2016 | 71160000 | 51872000 |
| Sunday, January 1, 2017 | 70644000 | 71772000 |
| Monday, January 1, 2018 | 70418000 | 97501000 |
| Tuesday, January 1, 2019 | 63238000 | 118590000 |
| Wednesday, January 1, 2020 | 59777000 | 169802000 |
| Friday, January 1, 2021 | 60152000 | 192507000 |
| Saturday, January 1, 2022 | 54540000 | 199563000 |
| Sunday, January 1, 2023 | 52243000 | 253598000 |
| Monday, January 1, 2024 | 64536000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Taro Pharmaceutical Industries Ltd. and Xencor, Inc. have demonstrated contrasting strategies in their R&D investments.
Taro's R&D expenses have shown a steady trend, peaking in 2016 with a 14% increase from 2014. However, by 2023, their spending had decreased by approximately 9% from its peak, reflecting a more conservative approach in recent years.
In contrast, Xencor's R&D spending has skyrocketed, with a staggering 1,270% increase from 2014 to 2023. This aggressive investment strategy underscores their commitment to innovation and growth.
As we look to the future, these trends highlight the diverse strategies companies employ to stay ahead in the ever-evolving pharmaceutical landscape.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Research and Development Expenses Breakdown: Incyte Corporation vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Exelixis, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Insights: How MannKind Corporation and Taro Pharmaceutical Industries Ltd. Allocate Funds
R&D Spending Showdown: Evotec SE vs Xencor, Inc.